Antònia Campolongo

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease

Saül Martínez‐Horta, Jesús Pérez‐Pérez, Erik van Duijn et al. · Parkinsonism & Related Disorders · 2016 · 156 citations

Life Sciences, Neurology, Neuroscience +9

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course

Núria Setó‐Salvia, Javier Pagonabarraga, Henry Houlden et al. · Movement Disorders · 2011 · 155 citations

Life Sciences, Genetics, Neurology +14

Dementia Risk in Parkinson Disease

Núria Setó‐Salvia, Jordi Clarimón, Javier Pagonabarraga et al. · Archives of Neurology · 2011 · 144 citations · Full text

Medicine, Genetics, Neurology +17

Measuring functional impact of cognitive impairment: Validation of the Parkinson's Disease Cognitive Functional Rating Scale

Jaime Kulisevsky, Ramón Fernández de Bobadilla, Javier Pagonabarraga et al. · Parkinsonism & Related Disorders · 2013 · 94 citations

Medicine, Neurology, Neuroscience +16

Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry

Maríateresa Buongiorno, Francesca Antonelli, Ana Cámara et al. · Parkinsonism & Related Disorders · 2015 · 89 citations

Medicine, Neurology, Pharmacotherapy +10